Does treatment with repeated doses of albendazole reduce hookworm reinfection rates in an endemic tribal population?
Not Applicable
- Registration Number
- CTRI/2013/05/003676
- Lead Sponsor
- Christian Medical College Vellore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 1350
Inclusion Criteria
1. Permanent resident of the village
2. Willing to stay in the area for the duration of follow-up
3. Willing to have study personnel visit at home
Exclusion Criteria
1. Individuals with syndromic or serological evidence of HIV infection or immunocompromise
2. Individuals who have received albendazole within the last 6 months
3. Pregnant women, individuals with a history of seizure, epilepsy or known neurological disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the number of infected people (cure rate, CR)Timepoint: One year post-treatment
- Secondary Outcome Measures
Name Time Method Reduction in faecal egg counts (FECR)Timepoint: After each cycle of albendazole, and one year post-treatment